CLOV US18914F1030

Report

Delayed Nasdaq - 04:00 2022-08-05 pm EDT
3.260	USD		+9.76%

08/03	Clover Health to Present at Canaccord Genuity 42nd Annual Growth Conference on August 10, 2022	AQ
07/26	Clover Health Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)	GL
07/26	Clover Health Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)	GL

Summary

Quotes 5-day view Delayed Quote.

Delayed Nasdaq

08/01/2022	08/02/2022	08/03/2022	08/04/2022	08/05/2022	Date
2.92(c)	3.1(c)	3.08(c)	2.97(c)	3.26(c)	Last
6 209 483	9 283 311	7 410 965	6 833 507	10 441 706	Volume
+4.29%	+6.16%	-0.65%	-3.57%	+9.76%	Change

More quotes

Estimated financial data (e) (USD)

Sales 2022	3 306 M - -
Net income 2022	-361 M - -
Net cash position 2022	108 M - -
P/E ratio 2022	-4,16x
Yield 2022	-

Sales 2023	4 190 M - -
Net income 2023	-292 M - -
Net cash position 2023	305 M - -
P/E ratio 2023	-5,29x
Yield 2023	-

Capitalization	1 535 M 1 535 M -
EV / Sales 2022	0,43x
EV / Sales 2023	0,29x
Nbr of Employees	680
Free-Float	69,9%

More Financials

Company

Clover Health Investments, Corp. is a healthcare technology company. The Companyâ€™s segments include Medicare Advantage (MA) and Direct Contracting (DC). The MA segment is an insurance business model that focuses on leveraging the Clover Assistant at the point of care. The Companyâ€™s DC segment is similar to the cost management and care coordination model accounted for as a performance guarantee, where Clover is...

Sector

Advanced Medical Equipment & Technology

Calendar

08/08

Earnings Release

More about the company

Ratings of Clover Health Investments, Corp.

Trading Rating :

Investor Rating :

ESG Refinitiv :

More Ratings

All news about CLOVER HEALTH INVESTMENTS, CORP.

08/03	Clover Health to Present at Canaccord Genuity 42nd Annual Growth Conference on August 1..	AQ
07/26	Clover Health Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)	GL
07/26	Clover Health Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)	GL
07/26	Clover Health Investments, Corp. Appoints Scott J. Leffler as its Chief Financial Offic..	CI
07/26	CLOVER HEALTH INVESTMENTS, CORP. /DE : Change in Directors or Principal Officers, Financia..	AQ
07/26	Dr. Carladenise Armbrister Edwards Joins Clover Health Board of Directors	GL
07/26	Clover Health Investments, Corp. Announces Appointment of Carladenise Armbrister Edward..	CI
07/14	Clover Health Investments Plans Medicare Advantage Expansion	MT
07/14	Clover Health Announces Planned Medicare Advantage Expansion for 2023	GL
07/11	Clover Health to Report Second Quarter 2022 Financial Results on August 8, 2022	AQ
06/24	Clover Health Investments to Join Russell 3000 Index on June 27	MT
06/24	Clover Health Set to Join Russell 3000® Index	AQ
06/24	CLOVER HEALTH INVESTMENTS, CORP.(NAS : CLOV) added to Russell Small Cap Completeness Index	CI
06/24	CLOVER HEALTH INVESTMENTS, CORP.(NAS : CLOV) added to Russell 2000 Dynamic Index	CI
06/24	CLOVER HEALTH INVESTMENTS, CORP.(NAS : CLOV) added to Russell 3000E Index	CI

More news

News in other languages on CLOVER HEALTH INVESTMENTS, CORP.

07/26	Clover Health Investments, Corp. annonce la nomination de Carladenise Armbrister Edward..
07/14	Clover Health Investments prévoit l'expansion de Medicare Advantage
06/24	Clover Health Investments rejoindra l'indice Russell 3000 le 27 juin prochain
05/27	Clover Health Investments, Corp. annonce la démission de Nathaniel S. Turner comme memb..
05/25	Clover Health Investments nomme Scott Leffler au poste de directeur financier

More news

Analyst Recommendations on CLOVER HEALTH INVESTMENTS, CORP.

06/15	BofA Securities Adjusts Clover Health Investments Price Target to $2 From $2.50, Mainta..	MT
05/26	BofA Securities Assess Risks to Managed Care Sector Amid Shifting Regulatory Environmen..	MT
05/10	SVB Securities Raises Clover Health Investments Price Target to $3 From $2.50, Maintain..	MT

More recommendations

Provided by Scoopnest.com

Analysis

Palihapitiya says SPAC slowdown separated 'wheat from chaff'